Literature DB >> 23986576

The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus.

Isaac B Hilton1, Jeremy M Simon, Jason D Lieb, Ian J Davis, Blossom Damania, Dirk P Dittmer.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus which establishes latent infection in endothelial and B cells, as well as in primary effusion lymphoma (PEL). During latency, the viral genome exists as a circular DNA minichromosome (episome) and is packaged into chromatin analogous to human chromosomes. Only a small subset of promoters, those which drive latent RNAs, are active in latent episomes. In general, nucleosome depletion ("open chromatin") is a hallmark of eukaryotic regulatory elements such as promoters and transcriptional enhancers or insulators. We applied formaldehyde-assisted isolation of regulatory elements (FAIRE) followed by next-generation sequencing to identify regulatory elements in the KSHV genome and integrated these data with previously identified locations of histone modifications, RNA polymerase II occupancy, and CTCF binding sites. We found that (i) regions of open chromatin were not restricted to the transcriptionally defined latent loci; (ii) open chromatin was adjacent to regions harboring activating histone modifications, even at transcriptionally inactive loci; and (iii) CTCF binding sites fell within regions of open chromatin with few exceptions, including the constitutive LANA promoter and the vIL6 promoter. FAIRE-identified nucleosome depletion was similar among B and endothelial cell lineages, suggesting a common viral genome architecture in all forms of latency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986576      PMCID: PMC3807352          DOI: 10.1128/JVI.01685-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  102 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  D Dittmer; M Lagunoff; R Renne; K Staskus; A Haase; D Ganem
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

Authors:  J Nicholas; V R Ruvolo; W H Burns; G Sandford; X Wan; D Ciufo; S B Hendrickson; H G Guo; G S Hayward; M S Reitz
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

4.  The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Lagunoff; D Ganem
Journal:  Virology       Date:  1997-09-15       Impact factor: 3.616

5.  Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor.

Authors:  K Lin; C Y Dai; R P Ricciardi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.

Authors:  D H Kedes; M Lagunoff; R Renne; D Ganem
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.

Authors:  R Renne; W Zhong; B Herndier; M McGrath; N Abbey; D Kedes; D Ganem
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

View more
  24 in total

1.  Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Jason M Schifano; Kathleen Corcoran; Hemant Kelkar; Dirk P Dittmer
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 2.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

3.  Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.

Authors:  Rachele Bigi; Justin T Landis; Hyowon An; Carolina Caro-Vegas; Nancy Raab-Traub; Dirk P Dittmer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-14       Impact factor: 11.205

4.  Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.

Authors:  Thomas Günther; Sabrina Schreiner; Thomas Dobner; Uwe Tessmer; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

5.  Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs.

Authors:  Angela Park; Soohwan Oh; Kyle L Jung; Un Yung Choi; Hye-Ra Lee; Michael G Rosenfeld; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

6.  Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.

Authors:  Alexandre Mercier; Carolina Arias; Alexis S Madrid; Meghan M Holdorf; Don Ganem
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

7.  CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression.

Authors:  Christian Paris; Ieisha Pentland; Ian Groves; David C Roberts; Simon J Powis; Nicholas Coleman; Sally Roberts; Joanna L Parish
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 8.  Chromatinization of the KSHV Genome During the KSHV Life Cycle.

Authors:  Timsy Uppal; Hem C Jha; Subhash C Verma; Erle S Robertson
Journal:  Cancers (Basel)       Date:  2015-01-14       Impact factor: 6.639

9.  Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.

Authors:  Zsolt Toth; Kevin Brulois; Hye-Ra Lee; Yoshihiro Izumiya; Clifford Tepper; Hsing-Jien Kung; Jae U Jung
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

10.  LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.

Authors:  Jianhong Hu; Yajie Yang; Peter C Turner; Vaibhav Jain; Lauren M McIntyre; Rolf Renne
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.